Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioprotection by DNA ligands

R F Martin1, S Broadhurst, S D'Abrew

  • 1Trescowthick Research Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Australia.

The British Journal of Cancer. Supplement
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Descriptive analysis of the changes in Johne's disease management practices on Ontario dairy farms through repeat risk assessment.

Journal of dairy science·2022
Same author

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA).

Clinical immunology (Orlando, Fla.)·2019
Same author

Degradation of substituted thiophenes by bacteria isolated from activated sludge.

Microbial ecology·2013
Same author

Thiosulfate oxidation by obligately heterotrophic bacteria.

Microbial ecology·2013
Same author

Transcriptional control of cardiac fuel metabolism and mitochondrial function.

Cold Spring Harbor symposia on quantitative biology·2011
Same journal

The proceedings of the Cancer Research Campaign/Department of Health Symposium on Ethnic Minorities and Cancer.

The British journal of cancer. Supplement·1996
Same journal

Smoking cessation programmes targeted at black and minority ethnic communities.

The British journal of cancer. Supplement·1996
Same journal

Betel-quid and tobacco chewing among the United Kingdom's Bangladeshi community.

The British journal of cancer. Supplement·1996
Same journal

Ethnicity and health beliefs with respect to cancer: a critical review of methodology.

The British journal of cancer. Supplement·1996
Same journal

Eliciting lay beliefs across cultures: principles and methodology.

The British journal of cancer. Supplement·1996
Same journal

Cancer clinical outcomes for minority ethnic groups.

The British journal of cancer. Supplement·1996
See all related articles

Proamine, a modified Hoechst 33342, shows enhanced radioprotective activity and reduced cytotoxicity in V79 cells. This DNA-binding agent holds promise for improving radioprotection in cancer radiotherapy.

Area of Science:

  • Radiochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Radioprotective activity of Hoechst 33342 can potentially be enhanced by electron-donating substituents.
  • DNA-binding agents are explored for their role in cancer radiotherapy.

Purpose of the Study:

  • To synthesize and evaluate proamine, a novel Hoechst 33342 analog with a dimethylamino group, for enhanced radioprotective properties.
  • To assess the cytotoxicity and in vivo efficacy of proamine compared to Hoechst 33342.

Main Methods:

  • Clonogenic survival studies using V79 cells to determine radioprotective efficacy.
  • Cytotoxicity assays to compare proamine and Hoechst 33342.
  • Mouse lung model to evaluate in vivo radioprotection and drug delivery.

Related Experiment Videos

Main Results:

  • Proamine demonstrated significantly increased radioprotective activity compared to Hoechst 33342.
  • Proamine exhibited lower cytotoxicity than Hoechst 33342, enhancing achievable radioprotection.
  • In vivo studies in mice showed potential for topical application of DNA-binding radioprotectors.

Conclusions:

  • Proamine represents a promising radioprotective agent with improved efficacy and safety profile.
  • The findings support the development of DNA-binding radioprotectors for cancer radiotherapy, with potential for targeted delivery strategies.